Photoimmunology

Dermatologic Clinics

Volumn 32, Issue 3, 2014, Pages 277-290

  Elmets, Craig A ^a   Cala, Cather M ^b   Xu, Hui ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Chronic actinic dermatitis; Cutaneous lupus erythematosus; Nonmelanoma skin cancer; Photoimmunology; Photosensitivity; Phototherapy; Polymorphous light eruption; Ultraviolet radiation

Indexed keywords

ALPHA INTERMEDIN; CALCITONIN GENE RELATED PEPTIDE; INTERLEUKIN 10; INTERLEUKIN 12; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UROCANIC ACID;

ANTIGEN PRESENTING CELL; ATOPIC DERMATITIS; CANCER RISK; CELLULAR IMMUNITY; CHRONIC ACTINIC DERMATITIS; CUTANEOUS T CELL LYMPHOMA; CYTOKINE PRODUCTION; EVIDENCE BASED MEDICINE; EXPERIMENTAL STUDY; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; INNATE IMMUNITY; MASTOCYTOSIS; MOLECULAR DYNAMICS; MORPHEA; NONHUMAN; PHOTODERMATOSIS; PHOTOIMMUNOLOGIC DISEASE; PHOTOSENSITIVITY DISORDER; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; RADIATION EXPOSURE; RADIATION INJURY; REGULATORY T LYMPHOCYTE; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; SKIN DISEASE; SKIN LUPUS ERYTHEMATOSUS; ULTRAVIOLET A RADIATION; ULTRAVIOLET RADIATION; ADVERSE EFFECTS; DERMATOLOGY; RADIATION RESPONSE; SKIN; SKIN TUMOR; TRENDS;

ALLERGY AND IMMUNOLOGY; DERMATOLOGY; HUMANS; SKIN; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 84901687802     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2014.03.005     Document Type: Review

References (112)

1. Marks R., Rennie G., Selwood T.S. Spontaneous remission of solar keratoses: the case for conservative management. Br J Dermatol 1986, 115:649-655.
2. Hartevelt M.M., Bouwes Bavinck J.N., Kootte A.M., et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990, 49:506-509.
3. Bouwes-Bavinck J.N., Vermeer B.J., van-der-Woude F.J., et al. Relation between skin cancer and HLA antigens in renal-transplant patients. N Engl J Med 1991, 325:843-848.
4. Webb M.C., Compton F., Andrews P.A., et al. Skin tumours posttransplantation: a retrospective analysis of 28 years' experience at a single centre. Transplant Proc 1997, 29:828-830.
5. Jensen P., Moller B., Hansen S. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 2000, 42:307.
6. Euvrard S., Kanitakis J., Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003, 348:1681-1691.
7. Mellemgaard A., Geisler C.H., Storm H.H. Risk of kidney cancer and other second solid malignancies in patients with chronic lymphocytic leukemia. Eur J Haematol 1994, 53:218-222.
8. Maule M., Scelo G., Pastore G., et al. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. J Natl Cancer Inst 2007, 99:790-800.
9. Weimar V.M., Ceilley R.I., Goeken J.A. Cell-mediated immunity in patients with basal and squamous cell skin cancer. J Am Acad Dermatol 1980, 2:143-147.
10. Yoshikawa T., Rae V., Bruins-Slot W., et al. Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in man. J Invest Dermatol 1990, 95:530-536.
11. Kaporis H.G., Guttman-Yassky E., Lowes M.A., et al. Human basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment. J Invest Dermatol 2007, 127:2391-2398.
12. Stern R.S., Liebman E.J., Vakeva L. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA follow-up study. J Natl Cancer Inst 1998, 90:1278-1284.
13. Stern R.S. Carcinogenic risk of psoralen plus ultraviolet radiation therapy: evidence in humans. Natl Cancer Inst Monogr 1984, 66:211-216.
14. Volden G., Molin L., Thomsen K. PUVA-induced suppression of contact sensitivity to mustine hydrochloride in mycosis fungoides. Br Med J 1978, 2:865-866.
15. Moscicki R.A., Morison W.L., Parrish J.A., et al. Reduction of the fraction of circulating helper-inducer T cells identified by monoclonal antibodies in psoriatic patients treated with long-term psoralen/ultraviolet-A radiation (PUVA). J Invest Dermatol 1982, 79:205-208.
16. Morison W.L., Wimberly J., Parrish J.A., et al. Abnormal lymphocyte function following long-term PUVA therapy for psoriasis. Br J Dermatol 1983, 108:445-450.
17. Kripke M.L. Antigenicity of murine skin tumors induced by ultraviolet light. J Natl Cancer Inst 1974, 53:1333-1336.
18. Elmets C.A., Bergstresser P.R., Tigelaar R.E., et al. Analysis of mechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation. J Exp Med 1983, 158:781-794.
19. Schwarz A., Maeda A., Wild M.K., et al. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J Immunol 2004, 172:1036-1043.
20. Schwarz A., Navid F., Sparwasser T., et al. In vivo reprogramming of UV radiation-induced regulatory T-cell migration to inhibit the elicitation of contact hypersensitivity. J Allergy Clin Immunol 2011, 128:826-833.
21. Moodycliffe A.M., Nghiem D., Clydesdale G., et al. Immune suppression and skin cancer development: regulation by NKT cells. Nat Immunol 2000, 1:521-525.
22. Xu H., Timares L., Elmets C.A. Host defenses in the skin. Clinical immunology: principles and practice 2013, 228-238. Elsevier Saunders, St. Louis, MO. 4th edition. R.R. Rich, T.A. Fleisher, W.T. Shearer (Eds.).
23. Ullrich S.E., Byrne S.N. The immunologic revolution: photoimmunology. J Invest Dermatol 2012, 132:896-905.
24. Schwarz T. 25 years of UV-induced immunosuppression mediated by T cells-from disregarded T suppressor cells to highly respected regulatory T cells. Photochem Photobiol 2008, 84:10-18.
25. Schwarz A., Noordegraaf M., Maeda A., et al. Langerhans cells are required for UVR-induced immunosuppression. J Invest Dermatol 2010, 130:1419-1427.
26. Shreedhar V., Giese T., Sung V.W., et al. A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J Immunol 1998, 160:3783-3789.
27. Kurimoto I., Streilein J.W. Tumor necrosis factor-alpha impairs contact hypersensitivity induction after ultraviolet B radiation via TNF-receptor 2 (p75). Exp Dermatol 1999, 8:495-500.
28. Streilein J.W. Sunlight and skin-associated lymphoid tissues (SALT): if UVB is the trigger and TNF alpha is its mediator, what is the message?. J Invest Dermatol 1993, 100:47S-52S.
29. Yoshikawa T., Streilein J.W. Genetic basis of the effects of ultraviolet light B on cutaneous immunity. Evidence that polymorphism at the TNFa and Lps loci governs susceptibility. Immunogenetics 1990, 32:398-405.
30. Meunier L., Bata-Csorgo Z., Cooper K.D. In human dermis, ultraviolet radiation induces expansion of a CD36+ CD11b+ CD1- macrophage subset by infiltration and proliferation; CD1+ Langerhans-like dendritic antigen-presenting cells are concomitantly depleted. J Invest Dermatol 1995, 105:782-788.
31. Cooper K.D., Oberhelman L., Hamilton T.A., et al. UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion. Proc Natl Acad Sci U S A 1992, 89:8497-8501.
32. Applegate L.A., Ley R.D., Alcalay J., et al. Identification of the molecular target for the suppression of contact hypersensitivity by ultraviolet radiation. J Exp Med 1989, 170:1117-1131.
33. Kripke M.L., Cox P.A., Alas L.G., et al. Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice. Proc Natl Acad Sci U S A 1992, 89:7516-7520.
34. Sreevidya C.S., Fukunaga A., Khaskhely N.M., et al. Agents that reverse UV-Induced immune suppression and photocarcinogenesis affect DNA repair. J Invest Dermatol 2010, 130:1428-1437.
35. Elmets C.A., LeVine M.J., Bickers D.R. Action spectrum studies for induction of immunologic unresponsiveness to dinitrofluorobenzene following in vivo low dose ultraviolet radiation. Photochem Photobiol 1985, 42:391-397.
36. Norris P.G., Limb G.A., Hamblin A.S., et al. Immune function, mutant frequency and cancer risk in the DNA repair defective genodermatoses xeroderma pigmentosum, Cockayne's syndrome and trichothiodystrophy. J Invest Dermatol 1990, 94:94-100.
37. Gaspari A.A., Fleisher T.A., Kraemer K.H. Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum. J Clin Invest 1993, 92:1135-1142.
38. Wysenbeek A.J., Weiss H., Duczyminer-Kahana M., et al. Immunologic alterations in xeroderma pigmentosum patients. Cancer 1986, 58:219-221.
39. Morison W.L., Bucana C., Hashem N., et al. Impaired immune function in patients with xeroderma pigmentosum. Cancer Res 1985, 45:3929-3931.
40. Dupuy J.M., Lafforet D. A defect of cellular immunity in Xeroderma pigmentosum. Clin Immunol Immunopathol 1974, 3:52-58.
41. Cafardi J.A., Elmets C.A. T4 endonuclease V: review and application to dermatology. Expert Opin Biol Ther 2008, 8:829-838.
42. Yarosh D., Klein J., O'Connor A., et al. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Lancet 2001, 357:926-929.
43. Noonan F.P., DeFabo E.C., Morrison H. Cis-urocanic acid, a product formed by ultraviolet B irradiation of the skin, initiates an antigen presentation defect in splenic dendritic cells in vivo. J Invest Dermatol 1988, 90:92-99.
44. Kock A., Schwarz T., Kirnbauer R., et al. Human keratinocytes are a source for tumor necrosis factor a: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 1990, 172:1609-1614.
45. Pentland A.P., Mahoney M., Jacobs S.C., et al. Enhanced prostaglandin synthesis after ultraviolet injury is mediated by endogenous histamine stimulation. J Clin Invest 1990, 86:566-574.
46. Chung H.T., Burnham D.K., Robertson B., et al. Involvement of prostaglandins in the immune alterations caused by the exposure of mice to ultraviolet radiation. J Immunol 1986, 137:2478-2484.
47. Walterscheid J.P., Nghiem D.X., Kazimi N., et al. Cis-urocanic acid, a sunlight-induced immunosuppressive factor, activates immune suppression via the 5-HT2A receptor. Proc Natl Acad Sci U S A 2006, 103:17420-17425.
48. Dy L.C., Pei Y., Travers J.B. Augmentation of ultraviolet B radiation-induced tumor necrosis factor production by the epidermal platelet-activating factor receptor. J Biol Chem 1999, 274:26917-26921.
49. Zhang Q., Yao Y., Konger R.L., et al. UVB radiation-mediated inhibition of contact hypersensitivity reactions is dependent on the platelet-activating factor system. J Invest Dermatol 2008, 128:1780-1787.
50. Seiffert K., Granstein R.D. Neuropeptides and neuroendocrine hormones in ultraviolet radiation-induced immunosuppression. Methods 2002, 28:97-103.
51. Black H.S. Potential involvement of free radical reactions in ultraviolet light-mediated cutaneous damage. Photochem Photobiol 1987, 46:213-221.
52. Garssen J., Buckley T.L., Van Loveren H. A role for neuropeptides in UVB-induced systemic immunosuppression. Photochem Photobiol 1998, 68:205-210.
53. Legat F.J., Jaiani L.T., Wolf P., et al. The role of calcitonin gene-related peptide in cutaneous immunosuppression induced by repeated subinflammatory ultraviolet irradiation exposure. Exp Dermatol 2004, 13:242-250.
54. Grabbe S., Bhardwaj R.S., Mahnke K., et al. alpha-melanocyte-stimulating hormone induces hapten-specific tolerance in mice. J Immunol 1996, 156:473-478.
55. Hosoi J., Murphy G.F., Egan C.L., et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 1993, 363:159-163.
56. Bhardwaj R.S., Schwarz A., Becher E., et al. Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol 1996, 156:2517-2521.
57. Redondo P., Garcia-Foncillas J., Okroujnov I., et al. Alpha-MSH regulates interleukin-10 expression by human keratinocytes. Arch Dermatol Res 1998, 290:425-428.
58. Rivas J.M., Ullrich S.E. The role of IL-4, IL-10, and TNF-alpha in the immune suppression induced by ultraviolet radiation. J Leukoc Biol 1994, 56:769-775.
59. Rivas J.M., Ullrich S.E. Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. J Immunol 1992, 149:3865-3871.
60. Toichi E., Lu K.Q., Swick A.R., et al. Skin-infiltrating monocytes/macrophages migrate to draining lymph nodes and produce IL-10 after contact sensitizer exposure to UV-irradiated skin. J Invest Dermatol 2008, 128:2705-2715.
61. Schwarz A., Maeda A., Kernebeck K., et al. Prevention of UV radiation-induced immunosuppression by IL-12 is dependent on DNA repair. J Exp Med 2005, 201:173-179.
62. Schmitt D.A., Walterscheid J.P., Ullrich S.E. Reversal of ultraviolet radiation-induced immune suppression by recombinant interleukin-12: suppression of cytokine production. Immunology 2000, 101:90-96.
63. Schwarz A., Stander S., Berneburg M., et al. Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Nat Cell Biol 2002, 4:26-31.
64. Sharma S.D., Katiyar S.K. Dietary grape-seed proanthocyanidin inhibition of ultraviolet B-induced immune suppression is associated with induction of IL-12. Carcinogenesis 2006, 27:95-102.
65. Vaid M., Singh T., Li A., et al. Proanthocyanidins inhibit UV-induced immunosuppression through IL-12-dependent stimulation of CD8+ effector T cells and inactivation of CD4+ T cells. Cancer Prev Res (Phila) 2011, 4:238-247.
66. Katiyar S., Elmets C.A., Katiyar S.K. Green tea and skin cancer: photoimmunology, angiogenesis and DNA repair. J Nutr Biochem 2007, 18:287-296.
67. Meeran S.M., Katiyar S., Elmets C.A., et al. Silymarin inhibits UV radiation-induced immunosuppression through augmentation of interleukin-12 in mice. Mol Cancer Ther 2006, 5:1660-1668.
68. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu Rev Immunol 2003, 21:335-376.
69. Bernard J.J., Cowing-Zitron C., Nakatsuji T., et al. Ultraviolet radiation damages self-noncoding RNA and is detected by TLR3. Nat Med 2012, 18:1286-1290.
70. Ahmad I., Simanyi E., Guroji P., et al. Toll-like receptor-4 deficiency enhances repair of ultraviolet radiation induced cutaneous DNA damage by nucleotide excision repair mechanism. J Invest Dermatol 2013, [Epub ahead of print].
71. Ros A.M., Wennersten G. Current aspects of polymorphous light eruptions in Sweden. Photodermatol 1986, 3:298-302.
72. Honigsmann H. Polymorphous light eruption. Photodermatol Photoimmunol Photomed 2008, 24:155-161.
73. Khoo S.W., Tay Y.K., Tham S.N. Photodermatoses in a Singapore skin referral centre. Clin Exp Dermatol 1996, 21:263-268.
74. Majoie I.M., van Weelden H., Sybesma I.M., et al. Polymorphous light eruption-like skin lesions in welders caused by ultraviolet C light. J Am Acad Dermatol 2010, 62:150-151.
75. Norris P.G., Morris J., McGibbon D.M., et al. Polymorphic light eruption: an immunopathological study of evolving lesions. Br J Dermatol 1989, 120:173-183.
76. Norris P.G., Barker J.N., Allen M.H., et al. Adhesion molecule expression in polymorphic light eruption. J Invest Dermatol 1992, 99:504-508.
77. Kolgen W., Van Weelden H., Den Hengst S., et al. CD11b+ cells and ultraviolet-B-resistant CD1a+ cells in skin of patients with polymorphous light eruption. J Invest Dermatol 1999, 113:4-10.
78. Palmer R.A., Friedmann P.S. Ultraviolet radiation causes less immunosuppression in patients with polymorphic light eruption than in controls. J Invest Dermatol 2004, 122:291-294.
79. Roelandts R. Chronic actinic dermatitis. J Am Acad Dermatol 1993, 28:240-249.
80. Que S.K., Brauer J.A., Soter N.A., et al. Chronic actinic dermatitis: an analysis at a single institution over 25 years. Dermatitis 2011, 22:147-154.
81. Hawk J.L., Lim H.W. Chronic actinic dermatitis. Photodermatology 2007, 169-183. Informa Health, New York. H.W. Lim, H. Honigsmann, J.L. Hawk (Eds.).
82. Menage Hdu P., Sattar N.K., Haskard D.O., et al. A study of the kinetics and pattern of E-selectin, VCAM-1 and ICAM-1 expression in chronic actinic dermatitis. Br J Dermatol 1996, 134:262-268.
83. Fujita M., Miyachi Y., Horio T., et al. Immunohistochemical comparison of actinic reticuloid with allergic contact dermatitis. J Dermatol Sci 1990, 1:289-296.
84. Foering K., Chang A.Y., Piette E.W., et al. Characterization of clinical photosensitivity in cutaneous lupus erythematosus. J Am Acad Dermatol 2013, 69:205-213.
85. Foering K., Goreshi R., Klein R., et al. Prevalence of self-report photosensitivity in cutaneous lupus erythematosus. J Am Acad Dermatol 2012, 66:220-228.
86. Kim A., Chong B.F. Photosensitivity in cutaneous lupus erythematosus. Photodermatol Photoimmunol Photomed 2013, 29:4-11.
87. Scheinfeld N., Deleo V.A. Photosensitivity in lupus erythematosus. Photodermatol Photoimmunol Photomed 2004, 20:272-279.
88. Kuhn A., Wozniacka A., Szepietowski J.C., et al. Photoprovocation in cutaneous lupus erythematosus: a multicenter study evaluating a standardized protocol. J Invest Dermatol 2011, 131:1622-1630.
89. Lehmann P., Holzle E., Kind P., et al. Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol 1990, 22:181-187.
90. LeFeber W.P., Norris D.A., Ryan S.R., et al. Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes. J Clin Invest 1984, 74:1545-1551.
91. Orteu C.H., Sontheimer R.D., Dutz J.P. The pathophysiology of photosensitivity in lupus erythematosus. Photodermatol Photoimmunol Photomed 2001, 17:95-113.
92. Lin J.H., Dutz J.P., Sontheimer R.D., et al. Pathophysiology of cutaneous lupus erythematosus. Clin Rev Allergy Immunol 2007, 33:85-106.
93. Cafardi J.A., Pollack B.P., Elmets C.A. Phototherapy. Fitzpatrick's dermatology in general medicine 2012, 2841-2850. McGraw Hill, New York. 8th edition. L.A. Goldsmith (Ed.).
94. Krutmann J., Morita A., Elmets C.A. Mechanisms of Photo(chemo)therapy. Dermatological phototherapy and photodiagnostic methods 2009, 63-77. Springer-Verlag, Berlin. 2nd edition. J. Krutmann, H. Hönigsmann, C.A. Elmets (Eds.).
95. van Weelden H., De La Faille H.B., Young E., et al. A new development in UVB phototherapy of psoriasis. Br J Dermatol 1988, 119:11-19.
96. Parrish J.A., Jaenicke K.F. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981, 76:359-362.
97. Clayton T.H., Clark S.M., Turner D., et al. The treatment of severe atopic dermatitis in childhood with narrowband ultraviolet B phototherapy. Clin Exp Dermatol 2007, 32:28-33.
98. Ersoy-Evans S., Altaykan A., Sahin S., et al. Phototherapy in childhood. Pediatr Dermatol 2008, 25:599-605.
99. Jury C.S., McHenry P., Burden A.D., et al. Narrowband ultraviolet B (UVB) phototherapy in children. Clin Exp Dermatol 2006, 31:196-199.
100. Gathers R.C., Scherschun L., Malick F., et al. Narrowband UVB phototherapy for early-stage mycosis fungoides. J Am Acad Dermatol 2002, 47:191-197.
101. Boztepe G., Sahin S., Ayhan M., et al. Narrowband ultraviolet B phototherapy to clear and maintain clearance in patients with mycosis fungoides. J Am Acad Dermatol 2005, 53:242-246.
102. Stege H., Schopf E., Ruzicka T., et al. High-dose UVA1 for urticaria pigmentosa. Lancet 1996, 347:64.
103. Tuchinda C., Kerr H.A., Taylor C.R., et al. UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States. Photodermatol Photoimmunol Photomed 2006, 22:247-253.
104. Krutmann J., Czech W., Diepgen T., et al. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992, 26:225-230.
105. Krutmann J., Diepgen T.L., Luger T.A., et al. High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. J Am Acad Dermatol 1998, 38:589-593.
106. Plettenberg H., Stege H., Megahed M., et al. Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1999, 41:47-50.
107. Morita A., Werfel T., Stege H., et al. Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med 1997, 186:1763-1768.
108. Yin L., Yamauchi R., Tsuji T., et al. The expression of matrix metalloproteinase-1 mRNA induced by ultraviolet A1 (340-400 nm) is phototherapy relevant to the glutathione (GSH) content in skin fibroblasts of systemic sclerosis. J Dermatol 2003, 30:173-180.
109. Wlaschek M., Briviba K., Stricklin G.P., et al. Singlet oxygen may mediate the ultraviolet A-induced synthesis of interstitial collagenase. J Invest Dermatol 1995, 104:194-198.
110. Parrish J.A., Fitzpatrick T.B., Tanenbaum L., et al. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 1974, 291:1207-1211.
111. Rupoli S., Goteri G., Pulini S., et al. Long-term experience with low-dose interferon-alpha and PUVA in the management of early mycosis fungoides. Eur J Haematol 2005, 75:136-145.
112. Herrmann J.J., Roenigk H.H., Honigsmann H. Ultraviolet radiation for treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995, 9:1077-1088.